INTERFERON LAMBDA 4 AND USES THEREOF FOR TREATING HEPATIC INFLAMMATION AND LIVER DISEASE Read more about INTERFERON LAMBDA 4 AND USES THEREOF FOR TREATING HEPATIC INFLAMMATION AND LIVER DISEASE US Application 63/586,936Filed on 2023-09-29
Liquid Biopsy to Detect Cancer Early and Sensitively in Patients with Neurofibromatosis Type 1 Read more about Liquid Biopsy to Detect Cancer Early and Sensitively in Patients with Neurofibromatosis Type 1 US Application 63/486,555Filed on 2023-02-23
SCAVENGER RECEPTOR-A1 TARGETED LIPID NANOPARTICLE FOR APC DELIVERY OF MRNA VACCINES Read more about SCAVENGER RECEPTOR-A1 TARGETED LIPID NANOPARTICLE FOR APC DELIVERY OF MRNA VACCINES US Application 63/535,215Filed on 2023-08-29
T CELL RECEPTORS (TCRS) GENERATED AS A RESULT OF HPV VACCINE THERAPY AND METHODS OF TREATING PATIENTS WITH SAME Read more about T CELL RECEPTORS (TCRS) GENERATED AS A RESULT OF HPV VACCINE THERAPY AND METHODS OF TREATING PATIENTS WITH SAME US Application 63/503,578Filed on 2023-05-22
TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA Read more about TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA US Application 63/216,777Filed on 2021-06-30
Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis Read more about Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis US Application 63/262,788Filed on 2021-10-20
DEVELOPMENT OF NOVEL ANTIBODIES AND SINGLE CHAIN VARIABLE FRAGMENTS AGAINST EXTRACELLULAR PRAME Read more about DEVELOPMENT OF NOVEL ANTIBODIES AND SINGLE CHAIN VARIABLE FRAGMENTS AGAINST EXTRACELLULAR PRAME US Application 63/530,440Filed on 2023-08-02
HUMANIZED 40H3 ANTIBODY Read more about HUMANIZED 40H3 ANTIBODY US Application 63/525,493Filed on 2023-07-07
Method for manufacturing TCR-T cell therapy products targeting tumor antigen(s) from patients with HIV and cancer Read more about Method for manufacturing TCR-T cell therapy products targeting tumor antigen(s) from patients with HIV and cancer US Application 63/469,641Filed on 2023-05-30
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease Read more about Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease US Application 62/901,638Filed on 2019-09-17